Overview

Treatment of Polycythemia Vera With Gleevec

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety and effectiveness of patients with Polycythemia Vera treated with Gleevec.
Phase:
Phase 2
Details
Lead Sponsor:
Weill Medical College of Cornell University
Treatments:
Imatinib Mesylate